Tian Shijiao, Hong Hui, Luo Xiao, Zeng Qingze, Huang Peiyu, Zhang Minming
Department of Radiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Quant Imaging Med Surg. 2024 Mar 15;14(3):2296-2308. doi: 10.21037/qims-23-1032. Epub 2024 Feb 26.
Obesity is considered a risk factor for the development of several neurodegenerative diseases, including Parkinson's disease (PD). Recent studies have revealed that glymphatic function is compromised in PD patients. This study aims to investigate the impact of different body mass index (BMI) statuses on glymphatic system function in PD patients using the diffusion tensor image analysis along the perivascular space (DTI-ALPS) method.
This study used a cross-sectional study design. A total of 145 PD patients were retrospectively enrolled in Parkinson's Progression Markers Initiative (PPMI) from 2010-2013. Eligibility criteria included diagnosis of PD based on PPMI criteria. Diffusion tensor image (DTI) scans (diffusion gradient =64, b-value =1,000 s/mm, slice thickness =2 mm) were acquired, and the analysis along the perivascular space (ALPS) index of each subject was calculated. The patient cohort was categorized into three groups based on BMI: normal weight (N=49), overweight (N=69), and obese (N=27). The difference in ALPS index among groups was performed by one-way analysis of variance (ANOVA). Partial correlation analysis was used to observe the relationship between ALPS index, BMI status, and demographics. Spearman's rank correlation coefficient and multivariable linear regression analyses were used to identify factors associated with ALPS index.
PD patients with higher BMI exhibited a reduced ALPS index (normal weight > overweight > obese), and the ALPS index for patients with obesity was statistically significantly lower than that for patients with normal weight (P<0.001). After adjusting for age, sex, years of education, handedness, and disease duration, a significant negative correlation between the ALPS index and BMI was observed in the PD patients (R=-0.275, P<0.001). Furthermore, a negative correlation between the ALPS index and the severity of motor symptoms was identified in the subgroup of overweight (R=-0.318, P=0.01), rather than in the normal weight and obese groups.
High BMI has a negative impact on the glymphatic function in PD patients, suggesting that weight control may have clinical relevance in the management of PD patients.
肥胖被认为是包括帕金森病(PD)在内的几种神经退行性疾病发生的危险因素。最近的研究表明,PD患者的类淋巴功能受损。本研究旨在采用沿血管周围间隙的扩散张量成像分析(DTI-ALPS)方法,研究不同体重指数(BMI)状态对PD患者类淋巴系统功能的影响。
本研究采用横断面研究设计。2010年至2013年,共有145例PD患者回顾性纳入帕金森病进展标志物倡议(PPMI)。纳入标准包括根据PPMI标准诊断为PD。获取扩散张量成像(DTI)扫描(扩散梯度=64,b值=1000 s/mm²,层厚=2 mm),并计算每个受试者的沿血管周围间隙(ALPS)指数。根据BMI将患者队列分为三组:正常体重(N=49)、超重(N=69)和肥胖(N=27)。采用单因素方差分析(ANOVA)比较各组间ALPS指数的差异。采用偏相关分析观察ALPS指数、BMI状态和人口统计学特征之间的关系。采用Spearman等级相关系数和多变量线性回归分析确定与ALPS指数相关的因素。
BMI较高的PD患者ALPS指数降低(正常体重>超重>肥胖),肥胖患者的ALPS指数显著低于正常体重患者(P<0.001)。在调整年龄、性别、受教育年限、利手和病程后,PD患者的ALPS指数与BMI之间存在显著负相关(R=-0.275,P<0.001)。此外,在超重亚组中,ALPS指数与运动症状严重程度呈负相关(R=-0.318,P=0.01),而在正常体重和肥胖组中未观察到这种相关性。
高BMI对PD患者的类淋巴功能有负面影响,提示体重控制在PD患者的管理中可能具有临床意义。